Form 4 for IMNN Imunon, Inc.
Accepted 2022-07-20 00:00:00 ET · period of report 2022-07-18 · accession 0001062993-22-016571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-20 | 2022-07-18 | IMNN | Le Goff Corinne | Pres, CEO, Dir | A - Grant | $0.00 | +53.0K | 53.0K | New | $0 |
| D | 2022-07-20 | 2022-07-18 | IMNN | Le Goff Corinne | Pres, CEO, Dir | A - Grant | $0.00 | +177.0K | 177.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-18 | A | A | 53,000 | $0.00 | 53,000 | D | — | — | (F1) Represents grant of restricted stock which vests on July 18, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-07-18 | A | A | 177,000 | $0.00 | 177,000 | D | $1.95 · — to 2032-07-18 | 177,000 Common Stock | (F2) Represents grant of stock option which vests with respect to 25% of the shares on July 18, 2023 and the remaining 75% percent in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of July 18, 2026. |